Talk to Sam

+1 917 267 7886

Search inside this page

All regions

Free Market Research Guides to Download

Pathology Industry: Market Research Reports, Statistics and Analysis

  • Currently 5/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
3 reviews

(Photo: Stock.xchng)

Global Pathology Industry

 

Pathology involves the study of the damaging impact of disease on cells and tissues and the way in which the body seeks to protect and repair itself. Pathology can be divided into two main branches, namely clinical and anatomic.

 

1) Clinical pathology involves the analysis of bodily fluids to diagnose disease through laboratory testing. Pathologists study aspects of disease such as its cause, the way in which it develops, how disease changes cells and the clinical manifestations of this change. Chemical pathology involves biochemical testing of any bodily fluid, most commonly plasma or serum. This segment incorporates endocrinology, which is the study of endocrine gland cells and the tissues that produce them, immunology, and pharmacology, the study of drugs. In the branch of cytogenics pathologists study cells, particularly chromosomes. Cytogenetics has been used to study conditions such as Down syndrome. The Global Down Syndrome Foundation estimates Federal research funding was at $22 million in 2010.

 

Medical microbiology involves the analysis of microorganisms such as parasites, bacteria and viruses. This discipline provides information on how pathogens invade a host and the way in which the body protects itself. This allows medical professionals to determine how to best facilitate the immune system’s natural defense to heal infection. Advances in the field have led to vaccination against diseases such as tuberculosis. The discipline of medical microbiology includes the study of HIV. The Henry J. Kaiser Family Foundation reports 2011 federal spending on HIV/AIDS activities amounts to more than $20 billion in the US and almost $7 billion globally. With the World Health Organization estimating over 33 million people living with HIV in 2009 and close to 2 million deaths from AIDS, governments are likely to continue investing in pathology research into the disease.

 

2) The other main branch of pathology apart from clinical pathology is anatomic pathology, which involves the diagnosis of disease through laboratory analysis of the body. Anatomic pathology includes such fields of study as cytopathology, forensic pathology and surgical pathology. Forensic pathologists carry out autopsies on bodies to determine cause of death, disease or injury. It is a common practice in legal and criminal procedures and is often used to determine the circumstances of a person’s death.

 

Cytopathology involves the cellular study of disease and includes the screening process known as a pap smear, which is used to test for early signs of cervical cancer. Surgical pathology involves the analysis of biopsies and surgical resections. The former consists of removing a sample from a patient to make a diagnosis based on small structures to determine the presence of a tumor, and whether it is benign or malignant, in the treatment of cancer. Biopsy analysis is carried out to diagnose and treat other diseases such as those stemming from infection and inflammation. A surgical resection involves removing a diseased organ from a patient to avoid its continued damage to the body or its spreading to healthy surrounding organs.

 

 

...
More »

You might be interested in: cancer, diabete, cardiovascular disease, more »

» Download Public Reports

1-10 of about 7 600 reports
Pharmaceutical in The United States : Innovation and Technology Trends

Pharmaceutical in The United States : Innovation and Technology Trends

  • Industry report
  • May 2013
  • 41 pages

... As a collaborative program that will utilize a combination of next generation sequencing and related genomic technologies, capabilities and computational analyses to understand infectious ...

  • Industries: Pathology
  • Countries: United States
Arthritis Market in The United States

Arthritis Market in The United States

  • Industry report
  • May 2013
  • 38 pages

... Osteoarthritis incidence Incidence of osteoarthritis is higher in women than men and increases with age arthritis can be diagnosed either by symptoms (all) or by radiographic analysis (moderate to severe ...

  • Industries: Pathology
  • Countries: United States
U.S. Pharmaceutical Business

U.S. Pharmaceutical Business

  • Industry report
  • May 2013
  • 30 pages

... Policy research these guidelines recommend spinal manipulation as a Safe and effective Initial form of therapy back pain Leading reason for absenteeism Amenable to chiropracty 18 financial ...

  • Industries: Pathology
  • Countries: United States
Infectious Disease Industry Overview (infectious disease, blood disease)

Infectious Disease Industry Overview (infectious disease, blood disease)

  • Industry report
  • May 2013
  • 21 pages

... Outcomes and reduce resistance rates Decreased number of antimicrobial drugs in pipeline from Antimicrobial stewardship, Jamie winner. Management of infectious diseases 32nd annual madison clinical ...

  • Industries: Pathology
U.S. Pharmaceutical Business

U.S. Pharmaceutical Business

  • Industry report
  • May 2013
  • 33 pages
  • by Corporation

... Annually. Diabetic foot ulcers lead to over 82,000 amputations annually at a cost that are estimated to exceed $3.6 Billion annually. Hospitalization costs of ~$20,000 for a patient with a dfu; ~$60 ...

  • Industries: Pathology
  • Countries: United States
Pharmaceutical Sector in The United States

Pharmaceutical Sector in The United States

  • Industry report
  • May 2013
  • 6 pages
  • by Governmental Agency

... Such as heart attack, stroke, heart failure and end-stage kidney failure.13 cardiovascular diseases are costly to society; direct and indirect costs of cardiovascular diseases in the u.S. Are estimated ...

  • Industries: Pathology
  • Countries: United States
U.S. Pharmaceutical Industry

U.S. Pharmaceutical Industry

  • Industry report
  • May 2013
  • 46 pages

... Sorbentstm competition 38 no approved therapies in the eu or us to prevent or treat organ failure Sepsis Ards and ali Burn injury Trauma Severe acute pancreatitis Cardiopulmonary bypass ...

  • Industries: Pathology
  • Countries: United States
U.S. Brain Tumor Industry (brain tumor, glioblastoma)

U.S. Brain Tumor Industry (brain tumor, glioblastoma)

  • Industry report
  • May 2013
  • 24 pages

... Uncertainty was positively correlated to five poms-sf subscales, anger, confusion, depression, fatigue, and tension (all with p ...

  • Industries: Pathology
  • Countries: United States
Pharmaceutical Business Analysis

Pharmaceutical Business Analysis

  • Industry report
  • May 2013
  • 53 pages

... Guidelines say People with diabetes and hypertension should be treated to a systolic blood pressure goal of 140 mmhg. Lower systolic targets (such as ...

  • Industries: Pathology
The Swazi Pharmaceutical Industry

The Swazi Pharmaceutical Industry

  • Industry report
  • May 2013
  • 21 pages

... Production v livestock production v natural resources vdiscuss the roles of government on hiv/aids vdiscuss the roles of pepfar u.S government organization on hiv/aids vdiscuss the impact of hiv/aids ...

  • Industries: Pathology
  • Countries: Africa, World, Swaziland

» Purchase Premium Reports (From $ 75 - $ 7 438)

About 4 900 reports
Analytical Tool - Hematological Cancers

Analytical Tool - Hematological Cancers

  • $ 8 925
  • Industry report
  • April 2013
  • by Bioseeker

"Analytical Tool - Hematological Cancers" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in hematological cancers. It is ...

Odanacatib (osteoporosis) - Forecast And Market Analysi ...

February 2013 $ 6 995

Reclast (osteoporosis) - Forecast And Market Analysis T ...

February 2013 $ 6 995

Actonel (osteoporosis) - Forecast And Market Analysis T ...

February 2013 $ 6 995

Pth(1-31)nh2 (osteoporosis) - Forecast And Market Analy ...

February 2013 $ 6 995

Forteo (osteoporosis) - Forecast And Market Analysis To ...

February 2013 $ 6 995

Protelos (osteoporosis) - Forecast And Market Analysis ...

February 2013 $ 6 995

» Read our Company Profiles

About 200 Companies

GlaxoSmithKline P.L.C.

United States

Eli Lilly and Co.

United States

Novartis Inc.

Switzerland

Pfizer Inc.

United States

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.